VNX-206

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameVNX-206
Drug Alias NameVNX-206
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVironexis Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVironexis Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A